Insights

Innovative Biomarker Discovery Nucleai specializes in AI-powered spatial biology technology, making it an attractive partner for pharmaceutical companies seeking advanced tools for predictive biomarker discovery, especially in oncology applications like metastatic melanoma.

Recent Industry Recognition Being recognized as a Top 10 Spatial Biology Company of 2025 for three consecutive years underscores Nucleai's leadership and credibility, opening doors for strategic collaborations and enterprise-level sales opportunities.

Expanding Product Offerings With recent launches of deep learning models to automate spatial proteomics workflows, Nucleai offers innovative solutions that can be integrated into existing laboratory processes, providing potential upsell and cross-sell opportunities.

Strategic Partnerships Collaborations with major life science firms like Bio-Techne and presentation at prominent conferences indicate active engagement with key industry players, suggesting potential for joint ventures, licensing, and larger client engagements.

Revenue Growth Potential With a revenue range of $25 million to $50 million and ongoing product development, Nucleai presents a strong sales opportunity for companies seeking cutting-edge spatial biology solutions to accelerate drug development pipelines.

Similar companies to Nucleai

Nucleai Tech Stack

Nucleai uses 8 technology products and services including LinkedIn Ads, Crazy Egg, Cookiebot, and more. Explore Nucleai's tech stack below.

LinkedIn Ads
Advertising
Crazy Egg
Analytics
Cookiebot
Cookie Compliance
LottieFiles
Design
imagesLoaded
Javascript Libraries
Amazon ALB
Load Balancers
X-XSS-Protection
Security
Google Tag Manager
Tag Management

Media & News

Nucleai's Email Address Formats

Nucleai uses at least 2 format(s):

Nucleai Email Formats	Example	Percentage
First@nucleaimd.com	John@nucleaimd.com	75%
Last@nucleaimd.com	Doe@nucleaimd.com	13%
First.Last@nucleaimd.com	John.Doe@nucleaimd.com	7%
FLast@nucleaimd.com	JDoe@nucleaimd.com	4%
LFirst@nucleaimd.com	DJohn@nucleaimd.com	1%
First@nucleai.ai	John@nucleai.ai	100%

Frequently Asked Questions

Where is Nucleai's headquarters located?

Nucleai's main headquarters is located at Chicago, Illinois United States. The company has employees across 3 continents, including AsiaNorth AmericaEurope.

What is Nucleai's official website and social media links?

Nucleai's official website is nucleai.ai and has social profiles on LinkedIn.

What is Nucleai's NAICS code?

Nucleai's NAICS code is 5112 - Software Publishers.

How many employees does Nucleai have currently?

As of February 2026, Nucleai has approximately 72 employees across 3 continents, including AsiaNorth AmericaEurope. Key team members include Ceo: A. V.Cfo: G. M.Chief Operating Officer (coo): D. D. B.. Explore Nucleai's employee directory with LeadIQ.

What industry does Nucleai belong to?

Nucleai operates in the Software Development industry.

What technology does Nucleai use?

Nucleai's tech stack includes LinkedIn AdsCrazy EggCookiebotLottieFilesimagesLoadedAmazon ALBX-XSS-ProtectionGoogle Tag Manager.

What is Nucleai's email format?

Nucleai's email format typically follows the pattern of First@nucleaimd.com. Find more Nucleai email formats with LeadIQ.

When was Nucleai founded?

Nucleai was founded in 2018.

Nucleai

Q: What is Nucleai's official website and social media links?

Nucleai's official website is nucleai.ai. Nucleai has social profiles on LinkedIn.

Q: How many employees does Nucleai have currently?

Nucleai has approximately 72 employees.

Q: What technology does Nucleai use?

Nucleai's tech stack includes Linkedin Insight Tag, Facebook, DX Delivery Service, Preact, Unpkg.

Software DevelopmentIllinois, United States51-200 Employees

Nucleai Brings AI-powered spatial biology technology to the forefront of precision medicine to improve drug development, clinical treatment decisions, and patient outcomes.

Nucleai works with leading pharmaceutical companies, licensing its research platform for internal use, and collaborating in biomarkers discovery projects.

Nucleai’s Atom: The leading Spatial Biology Platform for Precision Medicine.